Literature DB >> 22619242

2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Benjamin A Lipsky1, Anthony R Berendt, Paul B Cornia, James C Pile, Edgar J G Peters, David G Armstrong, H Gunner Deery, John M Embil, Warren S Joseph, Adolf W Karchmer, Michael S Pinzur, Eric Senneville.   

Abstract

Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infection is defined by ≥2 classic findings of inflammation or purulence. Infections are then classified into mild (superficial and limited in size and depth), moderate (deeper or more extensive), or severe (accompanied by systemic signs or metabolic perturbations). This classification system, along with a vascular assessment, helps determine which patients should be hospitalized, which may require special imaging procedures or surgical interventions, and which will require amputation. Most DFIs are polymicrobial, with aerobic gram-positive cocci (GPC), and especially staphylococci, the most common causative organisms. Aerobic gram-negative bacilli are frequently copathogens in infections that are chronic or follow antibiotic treatment, and obligate anaerobes may be copathogens in ischemic or necrotic wounds. Wounds without evidence of soft tissue or bone infection do not require antibiotic therapy. For infected wounds, obtain a post-debridement specimen (preferably of tissue) for aerobic and anaerobic culture. Empiric antibiotic therapy can be narrowly targeted at GPC in many acutely infected patients, but those at risk for infection with antibiotic-resistant organisms or with chronic, previously treated, or severe infections usually require broader spectrum regimens. Imaging is helpful in most DFIs; plain radiographs may be sufficient, but magnetic resonance imaging is far more sensitive and specific. Osteomyelitis occurs in many diabetic patients with a foot wound and can be difficult to diagnose (optimally defined by bone culture and histology) and treat (often requiring surgical debridement or resection, and/or prolonged antibiotic therapy). Most DFIs require some surgical intervention, ranging from minor (debridement) to major (resection, amputation). Wounds must also be properly dressed and off-loaded of pressure, and patients need regular follow-up. An ischemic foot may require revascularization, and some nonresponding patients may benefit from selected adjunctive measures. Employing multidisciplinary foot teams improves outcomes. Clinicians and healthcare organizations should attempt to monitor, and thereby improve, their outcomes and processes in caring for DFIs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22619242     DOI: 10.1093/cid/cis346

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  312 in total

1.  Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.

Authors:  Stephan Kress; Helmut Anderten; Anja Borck; Guido Freckmann; Lutz Heinemann; Ulrike Holzmüller; Bernd Kulzer; Alexandra Portele; Oliver Schnell; Helga Varlemann; Claudia Zemmrich; Ralf Lobmann
Journal:  J Diabetes Sci Technol       Date:  2020-06-10

2.  Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.

Authors:  Roger V Ortines; Haiyun Liu; Lily I Cheng; Taylor S Cohen; Heather Lawlor; Abhishek Gami; Yu Wang; Carly A Dillen; Nathan K Archer; Robert J Miller; Alyssa G Ashbaugh; Bret L Pinsker; Mark C Marchitto; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 3.  Topical antimicrobial agents for treating foot ulcers in people with diabetes.

Authors:  Jo C Dumville; Benjamin A Lipsky; Christopher Hoey; Mario Cruciani; Marta Fiscon; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

4.  Application of white blood cell SPECT/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis.

Authors:  Julien Vouillarmet; Myriam Moret; Isabelle Morelec; Paul Michon; Julien Dubreuil
Journal:  Diabetologia       Date:  2017-09-02       Impact factor: 10.122

5.  Tracking Anti-Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity.

Authors:  Irvin Oh; Gowrishankar Muthukrishnan; Mark J Ninomiya; James D Brodell; Benjamin L Smith; Charles C Lee; Steven R Gill; Christopher A Beck; Edward M Schwarz; John L Daiss
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

6.  Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

Authors:  Anthony M Casapao; Susan L Davis; Viktorija O Barr; Kenneth P Klinker; Debra A Goff; Katie E Barber; Keith S Kaye; Ryan P Mynatt; Leah M Molloy; Jason M Pogue; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  Erythrocyte sedimentation rate and C-reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis.

Authors:  Suzanne Av van Asten; Daniel C Jupiter; Moez Mithani; Javier La Fontaine; Kathryn E Davis; Lawrence A Lavery
Journal:  Int Wound J       Date:  2016-03-08       Impact factor: 3.315

Review 9.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

10.  Severity of diabetic foot infection and rate of limb salvage.

Authors:  Dane K Wukich; Kimberlee B Hobizal; Maria Mori Brooks
Journal:  Foot Ankle Int       Date:  2013-01-14       Impact factor: 2.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.